The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes.
Open accessAbstract
1,25(OH)2 Vitamin D3 (VD3) and retinoic acid (RA) function as ligands for nuclear receptors which regulate transcription. Though the cardiovascular system is not thought to represent a classical target for these ligands, it is clear that both cardiac myocytes and vascular smooth muscle cells respond to these agents with changes in growth characteristics and gene expression. In this study we demonstrate that each of these ligands suppresses many of the phenotypic correlates of endothelin-induced hypertrophy in a cultured neonatal rat cardiac ventriculocyte model. Each of these agents reduced endothelin-stimulated ANP secretion in a dose-dependent fashion and the two in combination proved to be more effective than either agent used alone (VD3: 49%; RA:52%; VD3 + RA:80% inhibition). RA, at concentrations known to activate the retinoid X receptor, and, to a lesser extent, VD3 effected a reduction in atrial natriuretic peptide, brain natriuretic peptide, and alpha-skeletal actin mRNA levels. Similar inhibition (VD3:30%; RA:33%; VD3 + RA:59% inhibition) was demonstrated when cells transfected with reporter constructs harboring the relevant promoter sequences were treated with VD3 and/or RA for 48 h. These effects were not accompanied by alterations in endothelin-induced c-fos, c-jun, or c-myc gene expression, suggesting either that the inhibitory locus responsible for the reduction in the mRNA levels lies distal to the activation of the immediate early gene response or that the two are not mechanistically coupled. Both VD3 and RA also reduced [3H]leucine incorporation (VD3:30%; RA:33%; VD3 + RA:45% inhibition) in endothelin-stimulated ventriculocytes and, once again, the combination of the two was more effective than either agent used in isolation. Finally, 1,25(OH)2 vitamin D3 abrogated the increase in cell size seen after endothelin treatment. These findings suggest that the liganded vitamin D and retinoid receptors are capable of modulating the hypertrophic process in vitro and that agents acting through these or similar signaling pathways may be of value in probing the molecular mechanisms underlying hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Effects of cytochalasin and phalloidin on actin.
Cooper, J. A. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.4.1473 · Cited by 2,009
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Umesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Yu, V. C., Delsert, C., Andersen, B., Holloway, J. M., Devary, O. V., Näär, A. M., Kim, S. Y., Boutin, J.-M., Glass, C. K., & Rosenfeld, M. G. (1991) · Cell · doi:10.1016/0092-8674(91)90301-e · Cited by 1,205
Mendelsohn, C., Lohnes, D., Décimo, D., Lufkin, T., LeMeur, M., Chambon, P., & Mark, M. (1994) · Development · doi:10.1242/dev.120.10.2749 · Cited by 992
Cloning and expression of full-length cDNA encoding human vitamin D receptor.
Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J., & O'Malley, B. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3294 · Cited by 959
Chien, K. R., Knowlton, K. U., Zhu, G., & Chien, S. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1835945 · Cited by 794
A novel rapid assay for chloramphenicol acetyltransferase gene expression
Neumann, J., Morency, C. A., & Russian, K. O. (1987) · BioTechniques · Cited by 749
Kastner, P., Grondona, J. M., Mark, M., Gansmuller, A., LeMeur, M., Decimo, D., Vonesch, J.-L., Dollé, P., & Chambon, P. (1994) · Cell · doi:10.1016/0092-8674(94)90274-7 · Cited by 682
Shubeita, H. E., McDonough, P. M., Harris, A. N., Knowlton, K. U., Glembotski, C. C., Brown, J. H., & Chien, K. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30538-0 · Cited by 645
RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis.
Sucov, H. M., Dyson, E., Gumeringer, C. L., Price, J., Chien, K. R., & Evans, R. M. (1994) · Genes & Development · doi:10.1101/gad.8.9.1007 · Cited by 638
Sadoshima, J., Jahn, L., Takahashi, T., Kulik, T. J., & Izumo, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50052-7 · Cited by 605
Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., Nogami, A., Murumo, F., & Hiroe, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116579 · Cited by 573
Simpson, P., McGrath, A., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.51.6.787 · Cited by 426
Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats
Baker, K. M., Chernin, M. I., Wixson, S. K., & Aceto, J. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.2.h324 · Cited by 410
Bogoyevitch, M. A., Glennon, P. E., Andersson, M. B., Clerk, A., Lazou, A., Marshall, C. J., Parker, P. J., & Sugden, P. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42228-9 · Cited by 388
Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling.
Kliewer, S. A., Umesono, K., Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., & Evans, R. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1448 · Cited by 383
Merke, J., Milde, P., Lewicka, S., Hügel, U., Klaus, G., Mangelsdorf, D. J., Haussler, M. R., Rauterberg, E. W., & Ritz, E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114097 · Cited by 341
Duerr, R. L., Huang, S., Miraliakbar, H. R., Clark, R., Chien, K. R., & Ross, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117706 · Cited by 329
Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.
Ito, H., Hiroe, M., Hirata, Y., Fujisaki, H., Adachi, S., Akimoto, H., Ohta, Y., & Marumo, F. (1994) · Circulation · doi:10.1161/01.cir.89.5.2198 · Cited by 251
Waspe, L. E., Ordahl, C. P., & Simpson, P. C. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114554 · Cited by 202
Karns, L. R., Kariya, K.-I., & Simpson, P. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.410 · Cited by 183
Vitamin D3 and cardiovascular function in rats.
Weishaar, R. E., & Simpson, R. U. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113010 · Cited by 179
1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.
Mitsuhashi, T., Morris, R. C., & Ives, H. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115213 · Cited by 177
Interaction between retinoic acid and vitamin D signaling pathways.
Schräder, M., Bendik, I., Becker-André, M., & Carlberg, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46779-2 · Cited by 174
Dyson, E., Sucov, H. M., Kubalak, S. W., Schmid-Schönbein, G. W., DeLano, F. A., Evans, R. M., Ross, J., & Chien, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7386 · Cited by 167
Weishaar, R. E., Kim, S. N., Saunders, D. E., & Simpson, R. U. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.1.e134 · Cited by 155
Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cellsIn vitro
Merke, J., Hofmann, W. J., Goldschmidt, D., & Ritz, E. (1987) · Calcified Tissue International · doi:10.1007/bf02555253 · Cited by 151
Gustafson, T. A., Markham, B. E., & Morkin, E. (1986) · Circulation Research · doi:10.1161/01.res.59.2.194 · Cited by 131
Human and canine gene homologs of porcine brain natriuretic peptide
Seilhamer, J. J., Arfsten, A. E., Miller, J. A., Lundquist, P., Scarborough, R. M., Lewicki, J. A., & Porter, J. G. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80015-4 · Cited by 117
Retinoid-dependent pathways suppress myocardial cell hypertrophy.
Zhou, M. D., Sucov, H. M., Evans, R. M., & Chien, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7391 · Cited by 102
Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes.
Bishopric, N. H., Jayasena, V., & Webster, K. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74073-3 · Cited by 86
Kohno, M., Horio, T., Yokokawa, K., Yasunari, K., Ikeda, M., Minami, M., Kurihara, N., & Takeda, T. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80372-6 · Cited by 85
Divergent Regulation of the Human Atrial Natriuretic Peptide Gene by c-jun and c-fos
Kovačič-Milivojević, B., & Gardner, D. G. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.292-301.1992 · Cited by 76
Self-citationNegative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3.
Li, Q., & Gardner, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37635-4 · Cited by 60
Self-citationDivergent regulation of the human atrial natriuretic peptide gene by c-jun and c-fos.
Kovačič-Milivojević, B., & Gardner, D. G. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.292 · Cited by 51
Self-citationLaPointe, M. C., & Sitkins, J. R. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264660 · Cited by 38
O’Connell, T. D., Weishaar, R. E., & Simpson, R. U. (1994) · Endocrinology · doi:10.1210/endo.134.2.8299585 · Cited by 37
Cis-Active Determinants of Cardiac-Specific Expression in the Human Atrial Natriuretic Peptide Gene
Wu, J., Kovačič-Milivojević, B., LaPointe, M. C., Nakamura, K., & Gardner, D. G. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-9-1311 · Cited by 36
Self-citationThe discovery of 9-cis retinoic acid a hormone that binds the retinoid-X receptor
Tate, B. F., Levin, A. A., & Grippo, J. F. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90076-0 · Cited by 33
Cited by
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J.-C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., & Jurutka, P. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.325 · Cited by 1,421
Dusso, A. S., Brown, A. J., & Slatopolsky, E. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00336.2004 · Cited by 1,148
Pilz, S., März, W., Wellnitz, B., Seelhorst, U., Fahrleitner-Pammer, A., Dimai, H. P., Boehm, B. O., & Dobnig, H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0784 · Cited by 607
Xiang, W., Kong, J., Chen, S., Cao, L.-P., Qiao, G., Zheng, W., Liu, W., Li, X., Gardner, D. G., & Li, Y. C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2004 · Cited by 570
Self-citationThadhani, R., Appelbaum, E., Pritchett, Y., Chang, Y., Wenger, J., Tamez, H., Bhan, I., Agarwal, R., Zoccali, C., Wanner, C., et al. (2012) · JAMA · doi:10.1001/jama.2012.120 · Cited by 567
Metadata
- Authors
- Wu, J., Garami, M., Cheng, T., & Gardner, D. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-04-01
- Volume
- 97
- Issue
- 7
- Pages
- 1577-1588
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2003162718
- Cited by
- 257
- References
- 42
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.